• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性胸膜肺弹力纤维增生症患者的气胸:发生率、临床特征和危险因素。

Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors.

机构信息

Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan,

Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan,

出版信息

Respiration. 2021;100(1):19-26. doi: 10.1159/000511965. Epub 2021 Jan 5.

DOI:10.1159/000511965
PMID:33401281
Abstract

BACKGROUND

Idiopathic pleuroparenchymal fibroelastosis (PPFE) is a rare form of idiopathic interstitial pneumonia that is characterized by predominantly upper lobe pleural and subpleural lung parenchymal fibrosis. Pneumothorax is one of the major respiratory complications in PPFE patients; however, its clinical features are poorly understood.

OBJECTIVE

We aimed to investigate the complication of pneumothorax in patients with idiopathic PPFE.

METHODS

A retrospective multicenter study involving 89 patients who had been diagnosed with idiopathic PPFE was conducted. We investigated the cumulative incidence, clinical features, and risk factors of pneumothorax after the diagnosis of idiopathic PPFE.

RESULTS

Pneumothorax developed in 53 patients (59.6%) with 120 events during the observation period (41.8 ± 35.0 months). The cumulative incidence of pneumothorax was 24.8, 44.9, and 53.9% at 1, 2, and 3 years, respectively. Most events of pneumothorax were asymptomatic (n = 85; 70.8%) and small in size (n = 92; 76.7%); 30 patients (56.6%) had recurrent pneumothorax. Chest drainage was required in 23 pneumothorax events (19.2%), and a persistent air leak was observed in 13 (56.5%). Patients with pneumothorax were predominantly male and frequently had pathological diagnoses of PPFE and prior history of pneumothorax and corticosteroid use; they also had significantly poorer survival than those without pneumothorax (log-rank test; p = 0.001). Multivariate analysis revealed that a higher residual volume/total lung capacity ratio was significantly associated with the development of pneumothorax after the diagnosis.

CONCLUSION

Pneumothorax is often asymptomatic and recurrent in patients with idiopathic PPFE, leading to poor outcomes in some cases.

摘要

背景

特发性胸膜肺弹力纤维增生症(PPFE)是一种罕见的特发性间质性肺炎,其特征为主要在上肺胸膜和肺实质下区纤维化。气胸是 PPFE 患者的主要呼吸并发症之一;然而,其临床特征尚未被充分了解。

目的

我们旨在研究特发性 PPFE 患者气胸的并发症。

方法

进行了一项回顾性多中心研究,纳入了 89 名被诊断为特发性 PPFE 的患者。我们调查了特发性 PPFE 诊断后气胸的累积发生率、临床特征和危险因素。

结果

在观察期间(41.8±35.0 个月),53 名(59.6%)患者发生了 120 次气胸事件。气胸的累积发生率分别为 1 年、2 年和 3 年时的 24.8%、44.9%和 53.9%。大多数气胸事件为无症状(n=85;70.8%)和小量气胸(n=92;76.7%);30 名(56.6%)患者发生复发性气胸。23 次气胸事件需要行胸腔引流(19.2%),13 次(56.5%)气胸存在持续漏气。气胸患者主要为男性,常伴有特发性 PPFE 病理诊断、气胸病史和皮质类固醇使用史;与无气胸患者相比,他们的生存率显著更差(对数秩检验;p=0.001)。多变量分析显示,诊断后残气量/肺总量比值较高与气胸的发生显著相关。

结论

特发性 PPFE 患者的气胸常为无症状和复发性,在某些情况下导致不良结局。

相似文献

1
Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors.特发性胸膜肺弹力纤维增生症患者的气胸:发生率、临床特征和危险因素。
Respiration. 2021;100(1):19-26. doi: 10.1159/000511965. Epub 2021 Jan 5.
2
Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias.特发性间质性肺炎中的放射学胸膜肺实质纤维弹性组织增生样病变。
Respir Res. 2021 Nov 11;22(1):290. doi: 10.1186/s12931-021-01892-9.
3
Pleuroparenchymal fibroelastosis: Distinct pulmonary physiological features in nine patients.胸膜实质纤维弹性组织增生症:9例患者独特的肺生理特征
Respir Investig. 2015 Jul;53(4):149-55. doi: 10.1016/j.resinv.2015.02.003. Epub 2015 Mar 23.
4
Pleuroparenchymal fibroelastosis in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者的胸膜肺实质纤维弹性化。
Respirology. 2020 Oct;25(10):1046-1052. doi: 10.1111/resp.13796. Epub 2020 Mar 9.
5
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study.特发性胸膜肺弹力纤维增生症的临床诊断:一项回顾性多中心研究。
Respir Med. 2017 Dec;133:1-5. doi: 10.1016/j.rmed.2017.11.003. Epub 2017 Nov 6.
6
The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.特发性肺纤维化与胸膜肺弹力纤维增生症的异同。
Chron Respir Dis. 2019 Jan-Dec;16:1479973119867945. doi: 10.1177/1479973119867945.
7
Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.特发性胸膜肺弹力纤维增生症患者高分辨率 CT 下肺下叶间质病变的临床意义。
Respir Med. 2019 Jul-Aug;154:122-126. doi: 10.1016/j.rmed.2019.06.018. Epub 2019 Jun 20.
8
Clinical, radiological and pathological features of idiopathic and secondary interstitial pneumonia with pleuroparenchymal fibroelastosis in patients undergoing lung transplantation.肺移植患者特发性和继发性间质性肺炎伴胸膜肺弹力纤维增生的临床、影像学和病理学特征。
Histopathology. 2022 Mar;80(4):665-676. doi: 10.1111/his.14595. Epub 2022 Jan 5.
9
Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan.在日本,通过多学科讨论诊断出胸膜肺实质纤维弹性瘤。
Respir Med. 2018 Aug;141:190-197. doi: 10.1016/j.rmed.2018.06.022. Epub 2018 Jun 27.
10
Pleuroparenchymal fibroelastosis in heterogeneous clinical conditions: Clinicopathologic analysis of 7 cases.不同临床情况下的胸膜实质纤维弹性组织增生症:7例临床病理分析
Clin Respir J. 2018 Apr;12(4):1495-1502. doi: 10.1111/crj.12696. Epub 2017 Sep 7.

引用本文的文献

1
Korean Guidelines for the Diagnosis and Management of Interstitial Lung Disease: Other Forms of Interstitial Lung Disease.韩国间质性肺疾病诊断与管理指南:其他形式的间质性肺疾病
Tuberc Respir Dis (Seoul). 2025 Jul;88(3):454-476. doi: 10.4046/trd.2024.0181. Epub 2025 Mar 13.
2
Proposed Clinical Algorithm for Pleuroparenchymal Fibroelastosis (PPFE).胸膜实质纤维弹性组织增生症(PPFE)的拟用临床算法
J Clin Med. 2024 Jun 24;13(13):3675. doi: 10.3390/jcm13133675.
3
Prognostic significance of body mass index and weight loss in patients with idiopathic pleuroparenchymal fibroelastosis.
体重指数和体重减轻在特发性胸膜实质纤维弹性组织增生症患者中的预后意义
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Jun 28;41(2):e2024026. doi: 10.36141/svdld.v41i2.15291.
4
A Rare Case of Idiopathic Pleuro-Parenchymal Fibroelastosis Presenting With Bilateral Spontaneous Pneumothoraces.一例罕见的特发性胸膜-肺实质纤维弹性组织增生症伴双侧自发性气胸
Cureus. 2024 Mar 26;16(3):e56975. doi: 10.7759/cureus.56975. eCollection 2024 Mar.
5
Prognostic impact of the cross-sectional area of the erector spinae muscle in patients with pleuroparenchymal fibroelastosis.胸膜肺弹力纤维增生症患者竖脊肌横截面积的预后影响。
Sci Rep. 2023 Oct 12;13(1):17289. doi: 10.1038/s41598-023-44138-y.
6
Clinical significance of para-carinal air cysts in patients with pleuroparenchymal fibroelastosis: The relationship with pneumomediastinum and pneumothorax.胸膜肺弹力纤维增生症患者的副隆突气囊肿的临床意义:与纵隔气肿和气胸的关系。
Clin Respir J. 2023 Aug;17(8):805-810. doi: 10.1111/crj.13671. Epub 2023 Jul 28.
7
Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis.特发性胸膜肺实质纤维弹性组织增生症患者营养不良相关风险评估
ERJ Open Res. 2023 May 9;9(3). doi: 10.1183/23120541.00749-2022. eCollection 2023 May.
8
The world of rare interstitial lung diseases.罕见间质性肺疾病的世界。
Eur Respir Rev. 2023 Feb 7;32(167). doi: 10.1183/16000617.0161-2022. Print 2023 Mar 31.
9
Bilateral pneumothoraces with apical consolidations.双侧气胸伴肺尖实变。
Respirol Case Rep. 2022 Nov 16;10(12):e01066. doi: 10.1002/rcr2.1066. eCollection 2022 Dec.
10
A proposed prognostic prediction score for pleuroparenchymal fibroelastosis.特发性肺纤维化合并胸膜肺弹力纤维增生症的预后预测评分模型的建立。
Respir Res. 2021 Jul 30;22(1):215. doi: 10.1186/s12931-021-01810-z.